Aspirin may reduce liver cancer risk
Healthline Media UK Ltd | October 15, 2018
Researchers at Massachusetts General Hospital have found that regular aspirin use can reduce the risk of developing liver cancer. The findings — which appear in JAMA Oncology — support the results of prior studies on the same topic. Data from this report show that taking aspirin on a regular basis can lower the risk of developing liver cancer, or hepatocellular carcinoma (HCC). The scientists defined "a regular basis" as taking two or more 325-milligram tablets per week for 5 years or more.